Alexion and Moderna have an exclusive strategic agreement for the discovery and development of messenger RNA Therapeutics™ for rare diseases.

learn more

Moderna announces a landmark publication describing the first-ever protein production through messenger RNA therapeutics™.

learn more

Moderna and AstraZeneca have a strategic option agreement to develop up to forty messenger RNA Therapeutics™ for the treatment of serious cardiometabolic diseases and cancer.

learn more

We are delivering the next wave of innovation to treat serious illness.

here's how

We’ve assembled a team of scientists and drug hunters, executives and visionaries. Our experience is matched only by our passion.

get to know us

1
2
3
4
5

What's New

March 6, 2014

Moderna appoints biotechnology investment banking veteran Lorence Kim as Chief Financial Officer | Read more

February 19, 2014

Massachusetts Life Sciences Center awards tax incentive to Moderna Therapeutics | Read more

January 14, 2014

Moderna spins-out Onkaido Therapeutics to focus on the development of messenger RNA Therapeutics™ in oncology | Read more